Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

N.Y. Sen. Gillibrand Seeks Federal Action On Personal-Care Microbeads

This article was originally published in The Tan Sheet

Executive Summary

A federal interagency task force should include microbeads and microplastics from personal-care products on its list of Great Lakes contaminants, New York Senator Kirsten Gillibrand asserts in a letter to EPA Administrator Gina McCarthy.

You may also be interested in...



In Brief: House Microbead Bill; “Wrinkle-Prone” U.S. States; Pantene’s “Not Sorry”

A House bill introduced June 18 would ban the sale of personal-care products containing synthetic plastic microbeads by 2018; J&J’s RoC brand releases study identifying the U.S.’s most “wrinkle-prone” cities; Pantene urges women to reserve their apologies. More news in brief.

States Scramble To Legislate Against Cosmetic Microbeads, Triclosan

Following bills introduced in February by New York and California that would ban plastic microbeads from personal-care products because of suspected environmental effects, Ohio, Illinois, Minnesota and N.J. follow suit. Triclosan also earns the attention of policymakers, with bans proposed in two more states.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107101

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel